IP Library Patent Application 11497566
Patent Application
App. No. 11/497,566

Tumor eradication by inositol-tripyrophosphate

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/497,566
Abstract

The present invention relates to various salts of inositol tripyrophosphate including the calcium, lithium, beryllium, magnesium, potassium, strontium, barium, rubidium and cesium salts of inositol tripyrophosphate, compositions comprising these salts, methods of making the various salts, and methods of use of the above salts. Methods of use include administering the above salts in an effective amount in individuals for the treatment of various types of cancers, Alzheimer's disease, stroke and osteoporosis.

Claims (5)

1 . The calcium and sodium mixed salt of inositol tripyrophosphate.

2 . The calcium and sodium mixed salt of claim 1 , wherein the inositol tripyrophosphate is myo-inositol 1,6:2,3:4,5 tripyrophosphate.

3 . A pharmaceutical composition comprising the calcium salt of inositol tripyrophosphate and a pharmaceutically acceptable adjuvant, diluent, carrier, or excipient thereof.

4 . A method of treating cancer in a human or animal comprising administering to the human or animal an effective amount of the calcium and sodium mixed salt of inositol tripyrophosphate.

5 . The method of claim 4 , wherein the cancer is selected from one or more of the group consisting of breast cancer, prostrate cancer, renal cell cancer, brain cancer, ovarian cancer, colon cancer, bladder cancer, pancreatic cancer, stomach cancer, esophageal cancer, cutaneous melanoma, liver cancer, lung cancer, testicular cancer, kidney cancer, bladder cancer, cervical cancer, lymphoma, parathyroid cancer, penile cancer, rectal cancer, small intestine cancer, thyroid cancer, uterine cancer, Hodgkin's lymphoma, lip and oral cancer, skin cancer, leukemia, and multiple myeloma.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded May 17, 2010
From: UNIVERSITE DE STRASBOURG
To: NORMOXYS, INC.
Reel/Frame 024393/0509 →
NUNC PRO TUNC ASSIGNMENT Recorded Feb 24, 2010
From: NORMOXYS, INC.
To: NORMOXYS, INC.; UNIVERSITE DE STRASBOURG
Reel/Frame 023983/0977 →
CHANGE OF NAME Recorded Jun 12, 2009
From: OXYPLUS, INC.
To: NORMOXYS, INC.
Reel/Frame 022813/0892 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2007
From: NICOLAU, CLAUDE; LEHN, JEAN-MARIE
To: OXYPLUS, INC.
Reel/Frame 019001/0251 →